243 related articles for article (PubMed ID: 31663285)
1. Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery.
Huang Q; Xing SX; Zeng Y; Si HB; Zhou ZK; Shen B
Orthop Surg; 2019 Oct; 11(5):886-894. PubMed ID: 31663285
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery.
Samama CM; Laporte S; Rosencher N; Girard P; Llau J; Mouret P; Fisher W; Martínez-Martín J; Duverger D; Deygas B; Presles E; Cucherat M; Mismetti P;
N Engl J Med; 2020 May; 382(20):1916-1925. PubMed ID: 32223113
[TBL] [Abstract][Full Text] [Related]
3. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Anderson DR; Dunbar M; Murnaghan J; Kahn SR; Gross P; Forsythe M; Pelet S; Fisher W; Belzile E; Dolan S; Crowther M; Bohm E; MacDonald SJ; Gofton W; Kim P; Zukor D; Pleasance S; Andreou P; Doucette S; Theriault C; Abianui A; Carrier M; Kovacs MJ; Rodger MA; Coyle D; Wells PS; Vendittoli PA
N Engl J Med; 2018 Feb; 378(8):699-707. PubMed ID: 29466159
[TBL] [Abstract][Full Text] [Related]
4. Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
Ní Cheallaigh S; Fleming A; Dahly D; Kehoe E; O'Byrne JM; McGrath B; O'Connell C; Sahm LJ
Int J Clin Pharm; 2020 Jun; 42(3):853-860. PubMed ID: 32328957
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial :
Longo de Oliveira ALM; de Oliveira Pereira RF; Agati LB; Ribeiro CM; Kawamura Suguiura GY; Cioni CH; Bermudez M; Pirani MB; Caffaro RA; Castelli V; Resende Aguiar VC; Volpiani GG; Paschoa A; Scarlatelli Macedo AV; de Barros E Silva PGM; de Campos Guerra JC; Fareed J; Lopes RD; Ramacciotti E
Clin Appl Thromb Hemost; 2022; 28():10760296221132556. PubMed ID: 36474344
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis.
Hu B; Jiang L; Tang H; Hu M; Yu J; Dai Z
J Orthop Surg Res; 2021 Feb; 16(1):135. PubMed ID: 33581718
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
[TBL] [Abstract][Full Text] [Related]
9. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
Kakkar AK; Brenner B; Dahl OE; Eriksson BI; Mouret P; Muntz J; Soglian AG; Pap AF; Misselwitz F; Haas S;
Lancet; 2008 Jul; 372(9632):31-9. PubMed ID: 18582928
[TBL] [Abstract][Full Text] [Related]
10. Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin.
Rahman WA; Habsa GH; Al-Mohrej OA; Hammad M; Selim NM; Hammad A
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020938865. PubMed ID: 32700655
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
[TBL] [Abstract][Full Text] [Related]
12. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
[TBL] [Abstract][Full Text] [Related]
13. A RCT study of Rivaroxaban, low-molecular-weight heparin, and sequential medication regimens for the prevention of venous thrombosis after internal fixation of hip fracture.
Tang Y; Wang K; Shi Z; Yang P; Dang X
Biomed Pharmacother; 2017 Aug; 92():982-988. PubMed ID: 28605879
[TBL] [Abstract][Full Text] [Related]
14. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Rivaroxaban as Primary Venous Thromboprophylaxis in an Adult Trauma Population.
Kingdon LK; Miller EM; Savage SA
J Surg Res; 2019 Dec; 244():509-515. PubMed ID: 31336243
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V;
N Engl J Med; 2013 Feb; 368(6):513-23. PubMed ID: 23388003
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
Duggan ST
Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study.
Cohoon KP; De Sanctis Y; Haskell L; McBane RD; Spiro TE
J Thromb Haemost; 2018 Jul; 16(7):1278-1287. PubMed ID: 29753308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]